GCIA
DMII

Gabelli & Co Investment Advisers’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Hold
179,500
– – 0.26% 88
2026
Q1 		$1.79M Buy
+179,500
New +$1.79M 0.27% 80

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Gabelli & Co Investment Advisers's DMII Position: Q2 2026 in Review

Gabelli & Co Investment Advisers held its Drugs Made In America Acquisition II Corp (DMII) position steady in Q2 2026 at 179,500 shares worth $1.81M. The position accounts for 0.26% of the portfolio, ranked #88.

Gabelli & Co Investment Advisers first reported a position in DMII in Q1 2026 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Gabelli & Co Investment Advisers held 179,500 shares of Drugs Made In America Acquisition II Corp worth $1.81M as of Q2 2026.
  • Gabelli & Co Investment Advisers left its Drugs Made In America Acquisition II Corp share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp made up 0.26% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #88 holding.
  • Gabelli & Co Investment Advisers first reported a position in Drugs Made In America Acquisition II Corp in Q1 2026 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.